Galenea Receives $6M Equity Investment from The Stanley Medical Research Institute
Galenea Corp., a Cambridge, MA-based company that focuses on synaptic transmission, has received a $6m equity investment from The Stanley Medical Research Institute (SMRI). The company intends to use the capital for the development of its innovative pro-cognitive discovery program and the selection of a clinical candidate for the treatment of schizophrenia and other psychiatric […]